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Abstract
BACKGROUND: Mental health is a state of well-being in which an individual is able to
acknowledge ability levels, cope with the normal stresses of life, be a productive member of society
and contribute to the community.

An important consideration for DNP prepared nurses is

implementing principles of the Collaborative Care Model as a guiding framework to improve access
to evidence-based mental health care in a medical care setting.

PURPOSE: The purpose of this DNP project was to examine the demographic, clinical and
treatment characteristics of patients with both medical and psychiatric diagnoses admitted to an
Intensive Care Unit (ICU) of a hospital in a large healthcare system located in a metropolitan area
in the southeast United States.

METHODS: For the study in this DNP project, an exploratory, descriptive design with a
retrospective medical record review was conducted on 100 patients with both medical and
psychiatric diagnosis admitted to the ICU between July 1, 2018 and December 31, 2018. This
study was an exploration of demographic, clinical and treatment characteristics of patients with
both a medical and psychiatric diagnosis admitted to the ICU during the study period. The
relationships among and between the psychiatric medication reconciliation status, type of
psychiatric treatments received, length of stay and discharge disposition of the study sample were
explored.
RESULTS: Those who had psychiatric diagnosis on admission were more likely to be female
(60.0% vs. 40%), have a neurological condition as the admitting diagnosis (63%) and suffer from
co-existing medical diagnosis including cardiac/pulmonary (83%). The nonexclusive, primary
ii

psychiatric diagnosis was anxiety (75%), follow by depression (63%) with nearly three quarters of
the sample on a psychiatric medication prior to admission (71%). The most common psychiatric
medication was an antidepressant/mood stabilizer (56%). There were no significant differences in
admission diagnosis, co-existing medical diagnosis, restraint use, PRN medication use, psych
consult, disposition or length of stay between those with and without psychiatric medications on
admission.
CONCLUSION: There remains limited research concerning collaborative care in the inpatient
healthcare setting. The preliminary findings of this DNP project suggest the need for more
exploratory research that can guide practice and policies to enhance care for patients with
psychiatric and medical comorbidities in the ICU setting.
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An Evaluation of Preexisting Psychiatric Diagnosis:
Patient Outcomes in an Intensive Care Setting
Introduction
A mental illness is defined as a change or alteration in a person’s thinking, emotions,
behavior or a combination of these conditions (American Psychiatric Association (APA), 2018).
Mental illnesses can range from a phobia or intellectual disability, which does not limit one’s
functional abilities, to severe depression, schizophrenia, or substance abuse that may compromise
functioning and require hospitalization. A comorbid mental health condition occurs when an
individual suffers from co-existing mental and physical health conditions simultaneously. A recent
report from the Substance Abuse and Mental Health Services Administration (SAMHSA, 2017b)
defined comorbid mental and physical illnesses as the presence of two or more diseases that not
only co-exist but also tend to exacerbate prognosis and precipitate the number and severity of
complications, thereby compromising efficacy of treatments.
With the spiraling, unsustainable costs of healthcare today and the focus on reducing
overall healthcare costs, the cost of treatment for co-existing conditions is also a variable of
concern. Yoon and Bernell (2013) reported that adverse mental and physical illness events are
associated with as much as a threefold increase of clinical office visits and medication treatment.
For example, in comorbid diabetes and depression, patients are on a downward spiral as poor
glycemic control can lead to an increase in symptoms of depression, which in turn leads to
compromises in self-care as well as poor medication adherence and poor dietary regimens and
glycemic control. Although integrating the care of mental and physical illnesses reduces the
overall severity and cost of both conditions (SAMHSA, 2017b), current healthcare practice tends
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to address and treat these conditions separately. Increased education about mental illness to
primary care providers and a care delivery system designed around the efficacy of services using
a collaborative care model can provide a more integrated health model and lower overall healthcare
cost (Rolls, Davis, & Coupland, 2002).
Problem Statement
The majority of research to date reports on medical and psychiatric illnesses separately or
only medications for physical conditions.

Yet, fully integrated care, which provides

comprehensive care for both medical and psychiatric illnesses, can improve patient outcomes and
quality of care (Reiss-Brennan, et al., 2016). The majority of providers in the ICU setting do an
excellent job of managing patients’ physical needs. However, patient’s psychiatric needs may be
unmet, particularly when psychiatric medications are abruptly stopped upon admission to the ICU,
despite the occurrence of accurate medication reconciliation.

The practice of abrupt

discontinuation of psychiatric medications can cause an exacerbation of patient’s symptoms and
possibly result in psychosis (National Institutes of Mental Health, 2010). These reports support
the importance of studying the characteristics of patients admitted to the ICU with a psychiatric
diagnosis and how psychiatric diagnosis influences clinical and treatment use modalities.
Study Purpose/Aims
The purpose of this study was to examine the demographic, clinical and treatment
characteristics of patients with both medical and psychiatric diagnoses admitted to an Intensive
Care Unit (ICU) of a hospital in a large healthcare system located in a metropolitan area in the
southeast United States.
The specific aims were to:
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Conduct a retrospective electronic medical record review to examine the frequency in
which patients with a psychiatric diagnosis are admitted to the ICU.



Examine the frequency in which psychiatric medication reconciliations are completed for
patients with a psychiatric diagnosis who are admitted to the ICU.



Examine the relationship of a prior to admission psychiatric medication use and use of
recommended treatment modalities, patterns of service use and disposition upon discharge
from the hospital.
Theoretical Model
The theoretical model chosen to guide this Doctorate of Nursing Practice project was Lydia

E. Hall’s theory of Core, Care and Cure (1964). Kimball and colleagues (2017) suggested that
Hall viewed patients as three overlapping parts; the core (patient’s psyche), the care (intimate care
of the body) and the cure (the medical aspects of the patient). Hall described the cure as the
primary factor considered when a patient entered a hospital in the acute phase of a disease.
Because of the primary focus, Hall suggested that the hospital environment created a difficult
psychological experience for the ill individual. For instance, when the primary focus is on cure,
all efforts are focused on giving medications or treatments to resolve or improve the pathological
cause of the disease. In addition, healthcare providers tend to spend the majority of time working
towards a medical cure. However, providers may give little thought to the patient’s psychological
response to how the disease and treatment. In contrast, Hall’s Core, Care and Cure Theory expands
on the curative thinking to include a holistic, collaborative approach of caring for patients suffering
both medical and mental illnesses to include how the pathology affects the patient’s core. In sum,
Hall believed all three parts were equal and required equal attention (Alligood, 2014).
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Evidence Based Intervention
Despite Hall’s theory being developed in the 1960s, multiple collaborative or integrated
care models have only begun to emerge within the last 10 years in an effort to provide a more
holistic approach to patient care. One evidence-based intervention is the Collaborative Care Model
(CCM) developed by the American Psychiatric Association (APA) and the Academy of
Psychosomatic Medicine (APM). The CCM operationalizes the principles necessary to improve
access to evidence based mental health care in a medical care setting (APA, 2016). The CCM
provides an approach for both chronic medical and mental illnesses. The focus of the CCM is on
four core elements of integrating mental and primary health care. The core elements specify that
care must be: 1) team-driven, 2) population-focused, 3) measurement-guided, and 4) evidencebased. Although the CCM was originally designed to be implemented in a primary care setting
with the primary care physician (PCP) as the team leader, it can be expanded to all patient care
settings which involve multiple disciplines, including those who are providers in hospital settings.
The CCM stresses the need for a team based approach to patient care to include a
multidisciplinary group of professionals such as: 1) primary care physicians; 2) advanced practice
registered nurses; 3) case managers; 4) registered nurses; 5) social workers and 6) mental health
practitioners (APA, 2016). Typically, the primary care practitioner is the ultimate decision maker
in the patient’s care yet can readily draw on the expertise of the numerous other professionals of
the CCM team. The second core element of the CCM is the basis of population-focused care and
how the individual affects the overall health of a set population. In using systematic, diseasespecific, patient-reported outcome measures the CCM is measurement guided and able to track
individual patient health as well as the overall population health. Measureable outcome tracking
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allows for the identification of modifiable outcomes in which evidence-based interventions can be
implemented to improve the overall individual and population health.
Literature Review
Approximately 20% of all adults in the United States will experience a mental illness and
of those, 9% will have a substance abuse problem (APA, 2018). In Kentucky alone, the average
number of mentally unhealthy days was four out of the preceding 30 days studied. In addition,
during the year preceding the report, Kentucky’s incidence of adults experiencing a serious mental
illness was greater than 5%, compared to the average of 4% in the United States (SAMHSA,
2017a). Furthermore, more than 40% of all individuals in the United States have a chronic physical
illness (Centers for Disease Control and Prevention (CDC), (2012). People with co-existing
mental and physical health conditions tend to have even higher rates of chronic health conditions
including hypertension, asthma, diabetes, heart disease and stroke that are often secondary to the
side effects of psychotropic treatments, disparities in health care access and utilization of services
(De Hert et al., 2011).
Mental illness can lead to an impaired ability to engage in adequate self-care of the coexisting physical illness, thereby contributing to poor health outcomes and an increase in the
overall health care cost. Recent reports indicate that individuals who suffer from co-existing
mental and chronic physical health conditions experienced healthcare costs 75% higher than those
without a co-occurring mental and physical health illness (SAMHSA, 2017b). Even so, healthcare
professionals too often make a clear distinction between mental and physical illness when one
condition should not be addressed to the exclusion of the other.
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Comorbid mental and physical illnesses will affect an increasing number of individuals as
advances in medicine increases the likelihood of a prolonged life without curing diseases, thus
resulting in two or more co-existing illnesses (World Health Organization (WHO), 2005). In
addition, the overall increase in life expectancy, increased risk for late-onset diseases and
unhealthy life styles may contribute to an increased number of mental and chronic physical
illnesses in the population (WHO, 2015). In accordance with the increased number of chronic
mental and physical illnesses, treatment interventions are likely to result in greater use of
medications in treatment, especially for those with chronic illnesses. For example, the increased
number of medications for chronic illnesses highlights the importance of The Joint Commission
2019 Hospital National Patient Safety Goal of accurate and complete medication reconciliation
(The Joint Commission, 2018).
Medication reconciliation is the process of generating the most accurate listing of a
patient’s medications, including the drug name, dosage, frequency and route (Institute for
Healthcare Improvement, 2019). The goal of medication reconciliation is for the patient’s
medication listing to be reviewed at all transition points as the patient transverses the healthcare
process, in order to assure correct, appropriate continuation of the patient’s medications.
Discrepancies in medication reconciliation create inadvertent inconsistencies across care and leave
patients vulnerable to adverse drug events.

Although the inconsistencies typically are

unintentional, a 2018 study by the Agency for Healthcare Research and Quality (AHRQ) found
that more than 50% of hospitalized patients’ medication lists contained at least one discrepancy
and of those, 40% were identified to have the potential to cause harm.
Medication reconciliation is especially important for patients admitted to the ICU. Bell et
al. (2011) reported an increased risk of discontinuation of medications for physical conditions upon
10

admission to the ICU when compared to patients who are hospitalized but do not have an ICU
admission. Despite having a documented preexisting mental illness, greater than 20% of patients
reported developing depression during an ICU admission (Davydow, Gifford, Desai, Bienvenu &
Needham, 2009).

Furthermore, approximately 40% of patients admitted to the ICU were

diagnosed with anxiety following admission (Peris, et al., 2011). The nature of ICU admission
criteria and subsequent therapies place patients at risk for stressors, including but not limited to,
respiratory insufficiency, discomfort of tube insertions and labs draws, activation of the
inflammatory cascade which includes brain inflammation and potential delirium with psychotic
experiences relating to a lack of appropriate day-night cycling (Davydown et al., 2009).
With approximately 20% of adults experiencing a mental illness prior to admission to an
ICU, a lack of appropriate medication reconciliation can truly create harm and risks for patient
safety (APA, 2018). Patients admitted to the ICU are already extremely physically ill and abruptly
discontinuing prescribed psychiatric medications can lead to changes in sleep, increased anxiety,
difficulty with emotions, sadness or tearfulness, fatigue, memory or concentration problems, flulike physical symptoms and diarrhea or constipation (Ostrow, Jessell, Hurd, Darrow & Cohen,
2017). Along with the physical symptoms, abruptly stopping psychiatric medications can lead to
a reemergence of mental illness symptomatology, possibly create or increase existing suicidal
ideations as well as explosive outburst and psychosis which may results in an increased length of
stay (Ostro et al., 2017). Lastly, stopping psychiatric medications can precipitate a loss of control
resulting in a setback in treatment regimens for patients with a mental illness, increasing the loss
of autonomy typically associated with an ICU admission. In order to obtain the correct treatment
regimen, patients with a mental illness may be forced to tolerate suffering and symptoms from four
to six weeks before obtaining an effective medication state (National Institute of Mental Health
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(NIMH), 2016). Patients admitted to the ICU are at high risk for poor physical recovery without
the added consequences associated with complications resulting from the lack of medication
reconciliation.
Agency Description
Setting
This DNP project was implemented at an Intensive Care Unit (ICU) of a hospital in a large
healthcare system located in a metropolitan area in the southeast United States. The ICU in the
study setting consists of 36 beds on two units of the acute-care setting. These combined ICU units
serve approximately 250 patients monthly; the majority have neurologic/neurosurgical, cardiac,
pulmonary, medical, surgical and renal critical care needs. In addition, many have several
comorbid medical illnesses in addition to a psychiatric diagnosis.
Target Population
The target population for the study was patients admitted to the ICU with a service level
of intensive and who had both psychiatric and medical diagnoses. The study period was July 1,
2018 to December 31, 2018 during which time, 230 medical records met criteria for study inclusion
out of the total 405 patients admitted to the ICU. Using a random number generator, a random
sample of 100 medical records was selected from the 230 eligible records.
Inclusion criteria for the study from the medical records of patients were: a) 18 years of
age or older, b) admitted with a service level designation of intensive to the ICU, c) admitted
between July 1, 2018 and December 31, 2018, and d) a documented past or current psychiatric
diagnosis. Exclusion criteria were: a) admitted or discharged with a legal status of incarceration.
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Congruence of DNP Project and Norton Healthcare
The mission of the healthcare organization and hospital of the study site is to provide
quality health care to all those in need, in a manner which responds to the needs of the community
and honors the faith heritage. This mission is achieved through vision and values statements about
being the most comprehensive, strongest health care organization who sets the standard of quality
care in the region and demonstrating stewardship of resources. This study, which examines the
demographic, clinical and treatment characteristics of patients with a psychiatric diagnosis in the
ICU, contributed to the organization’s mission, since assessing the appropriate standard of care
and resources for patients with a psychiatric diagnosis could result in improved patient care and
safety.
Description of Stakeholders
The stakeholders of this study included: the chief executive officers (CEOs), chief nursing
officers (CNOs) and chief financial officers (CFOs); hospitalist providers; intensivist providers;
registered nurses and patients with mental illnesses. The CEOs, CNOs and CFOs are in charge
of the day to day operations of the hospitals, assuring the quality of care and financial stewardship.
The hospitalist and intensivist providers are on the front line of patient care, responsible for the
reconciliation of patient medications and ultimately responsible for increased length of stays with
subsequent cost. The hospital and intensivist providers along with hospital nurses will also be
directly impacted by the implications and practice change suggestions which emerge from this
study. Lastly, patients who are diagnosed with a mental illness are the key stakeholders as they
will benefit from determining if collaborative care is being performed at the hospital ICU and any
practice change implications.

13

Site-specific Facilitators and Barriers to Implementation
Multiple facilitators within the organization and hospital helped in the process of
implementing this study. The chief nursing officer, ICU director and ICU manager approved and
supported the study. The Director of Patient Care Services and the organization’s data analytics
team was helpful in extracting critical data points from the medical records for review. An
important barrier identified in the study was the subjective nature of the documentation of mental
health diagnosis within the electronic medical record system. In addition, there are a limited
number of psychiatric providers within the healthcare system and therefore the majority of
documented preexisting, mental illnesses were self, patient reported.
Project Design
This study was based on a descriptive design with a retrospective medical record review to
extract data on 100 randomly selected medical records of patients admitted to the ICU between
July 1, 2018 and December 31, 2018 with both medical and psychiatric diagnoses. The data
extracted included the patients’ demographic, clinical and treatment characteristics, including the
admission diagnosis, co-existing medical diagnosis, psychiatric diagnosis, frequency of
psychiatric medication reconciliation, the use of recommended treatment modalities, patterns of
service use and disposition upon discharge.
Project Methods
Procedure
A university medical Institutional Review Board (IRB) and the healthcare organization’s
research office approved the study. Secondary to the retrospective nature of the study, a waiver of
documentation of informed consent was obtained as part of the approved IRB application.
14

Following study approval, data analytics staff compiled a list of potential medical records meeting
the study inclusion criteria. The Principal Investigator (PI) then reviewed each medical record for
inclusion and exclusion criteria. Once a list of eligible medical records was compiled, a sample of
100 medical records was selected using a random number generator. Each selected medical record
was then assigned a unique identification number known only to the PI. The PI then reviewed
each of the selected medical records to obtain information related to the variables listed in Table
1. This information was recorded on a paper data collection tool (Appendix A). The data were
then entered into an Excel spreadsheet and coded for use in SPSS. Due to the span of the data
points within the admission and co-existing medical diagnosis, type of psychiatric medication,
sitter use, time surrounding psychiatric consults, race/ethnicity and marital status, some original
categories were narrowed to facilitate interpretation of analysis.
Measures and Instruments
The following measures were extracted from the electronic medical records (Table 1):
1. Diagnoses: The diagnoses recorded included the admission diagnoses (neurological,
cardiac/pulmonary

and

other),

co-existing

medical

diagnoses

(neurological,

cardiac/pulmonary and other) and psychiatric diagnoses (schizophrenia, bipolar disorder,
depression, anxiety, post-traumatic stress disorder and intellectual disability).

The

diagnoses data were examined using frequencies and percentages.
2. Medication Reconciliation: The medication reconciliation reviews were used to
determine if the patients were on psychiatric medications prior to admission and, if so what
type the patients were taking (antipsychotic, antidepressant/ mood stabilizer and/or
anxiolytic), in addition to whether or not the medications were given to the patients during
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admission. The medication reconciliation data were examined using frequencies and
percentages.
3. Restraint use: Patient history of restraint use and type of restraints (medical or behavioral)
during the hospital stay were collected. The restraint use was compared to the prior to
admission psychiatric medications using chi-square analysis and the type of restraints used
were examined with frequencies and percentages.
4. Sitter use: Patient history of sitter use during the hospital stay was explored. The
proportion of patients who were on a prior to admission psychiatric medication and had a
sitter ordered were examined using chi-square analysis.
5. As needed medications: The use of as needed or PRN medications with the indication for
use listed as anxiety or agitation was recorded. The proportion of patients who were on a
prior to admission psychiatric medication and had an as needed medication ordered were
examined using chi-square analysis.
6. Psychiatric consult: Orders were reviewed for psychiatric providers consults during the
hospital stay along with the time between admission and when the order was placed, as
well as the duration between when the order was placed and the psychiatric provider
completed the consult. The proportion of patients who were on a prior to admission
psychiatric medication and had a psychiatric consult ordered were examined using chisquare analysis.
7. Length of stay: Total number of hours patients were admitted to the ICU and the overall
hospital stay were collected. The length of stay data were examined proportionately to the
four prior to admission psychiatric medication groups using Mann-Whitney U analyses and
interquartile ranges.
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8. Discharge disposition: The location of the patients upon discharge from the hospital
(home, rehab or deceased) were recorded. Chi-square analyses were used to examine the
differences between the four medication groups and the discharge disposition.
9. Demographics: The demographic data included gender (male vs. female), age (in years),
race (white, black, or Hispanic) and marital status (partnered or non-partnered) were
collected. The demographic data were examined using frequencies and percentages and
means and standard deviations.
Results
Sample Characteristics (Table 2 & 3)
The sample (N=100) was primarily female (60%), white (90%), non-partnered (55%) and
on average 54.02 (SD= 15.01) years of age. An overwhelming majority of the sample had a
primary admission diagnosis of a neurological condition (63%), followed by other diagnosis (22%)
and finally cardiac/pulmonary diagnosis (15%). The sample suffered from a significant percentage
of co-existing medical diagnoses including cardiac/pulmonary (83%) and other (83%) followed
by neurological (53%). The nonexclusive, primary psychiatric diagnosis was anxiety (75%),
followed by depression (63%).

Nearly three quarters of the sample was on a psychiatric

medication prior to admission (71%) including antidepressants/mood stabilizers (56%), followed
by anxiolytics (33%) and antipsychotics (16%).
Differences in Prior to Admission Psychiatric Medication Reconciliation Completion
As illustrated in Table 4, of the 71% of the sample that was on a psychiatric medication
prior to admission, antipsychotic medications (68.8%) and antidepressant/mood stabilizers
(76.8%) were restarted within 23 hours of admission at a significantly higher frequency when
17

compared to anxiolytic medications (39.4%). Of the sample whose medications were not started
prior to 23 hours from admission, all three medication groups (20.0%, 38.5% and 15.0%) had a
relatively low frequency of having a prior to admission psychiatric medication started between 24
hours and discharge. On the contrary, greater than 70% of the sample had prior to admission
psychiatric medications restarted or continued at discharge. While those in the sample on
anxiolytic medications had the lowest continuation of medication at less than 23 hours from
admission, the frequency of anxiolytic medications restarted at discharge nearly doubled (39.4%
vs. 72.7%). In addition, of the portion of the sample on antipsychotic medications (N=16), almost
one-third of this group (68.6% vs. 93.8%) was abruptly taken off the antipsychotic medication on
admission and then restarted on the medication upon discharge (see Table 4).
Treatment Modalities and Patterns of Service Use differences between those with and
without prior to Admission Psychiatric Medications.
Table 5 presents the differences in admission diagnosis, co-existing medical diagnoses,
restraint use, PRN medication use, psychiatric consults and disposition upon discharge between
the sample with and without a prior to admission psychiatric medication, along with differences
between the three psychiatric medication classifications.

Neurological admitting diagnoses

(68.8%, 71.4%, 66.7% and 48.3%) surpassed cardiac/pulmonary and other diagnoses in all
medication classifications, yet had the lowest percentage among the sample who were not on a
prior to admission psychiatric medication. There were no significant trends among co-existing
medical diagnoses in the different medical classifications. Restraint use overall was relatively low,
less than 40%, in the study sample across all medication classifications. Documentation of
psychiatric consult orders was also proportionately low across the entire sample population, with
the highest percentage being among those on an antipsychotic medication (25%). Overall, among
18

all medication classifications, the majority of the sample were discharged home followed by
rehabilitation.
While all of the above data showed trends among some of the medication classifications,
the only significant data involved PRN medication use among those who were on an anxiolytic
medication prior to admission. Of the sample who were on an anxiolytic prior to admission, both
the percentage of those who used a PRN medication (yes) and those who did not (no) was
statistically significant (45.5% and 54.5% respectively).
ICU and Hospital Length of Stay (LOS) difference between those with and without prior to
Admission Psychiatric Medications
Table 6 presents the differences between ICU and hospital length of stays (LOS) when
compared to the four medication classifications.

The ICU LOS of all four medication

classifications varied minimally within a few hours of one another. However, when compared to
those taking an antidepressant/mood stabilizer prior to admission, those taking an antipsychotic or
anxiolytic prior to admission had an overall longer median hospital LOS (59.0 hours vs. 90.0
hours). Overall, there were no significant differences in the ICU or hospital LOS in regards to the
medication classifications.
Discussion
This study examined the demographic and clinical characteristics of patients with both
medical and psychiatric diagnoses admitted to an ICU, as well as the impact of prior to admission
psychiatric medications on treatment characteristics. Based on literature searches (CINAHL,
Healthsource, MEDLINE and Proquest) studies of this type have not been reported and to my
knowledge, this is the first study to make comparisons between the type of psychiatric medications
19

a patient is taking and the ICU treatment characteristics. The main finding of this study was the
significantly higher percentage of the sample who suffered from a prior to admission psychiatric
diagnoses in comparison to the national average. In the United States, an average of 20% of
Americans suffering from a psychiatric illness yearly (APA, 2018). In this study, history of
psychiatric illnesses was largely self-reported; however, of the 405 patients admitted during the
study period 230 (56.8%) had a psychiatric diagnosis. Although this study finding cannot be
generalized, given the random sample determined for analysis, it is reasonable to question whether
or not half of all patients admitted to the ICU at the study hospital would have a psychiatric
diagnosis prior to admission requiring the attention of the hospital personnel.
In addition to the high percentage of the study sample having a psychiatric diagnosis,
medical records indicated that 75% had anxiety, 63% had depression and 71% were on a
psychiatric medication prior to admission. These percentages are higher than national estimates,
thus re-affirming the profound prevalence of psychiatric conditions within the sample population.
However, despite the high prevalence rates found in this study, it does not account for additional
portions of the population which may develop anxiety, depression or PTSD as a result of the ICU
stay. With advances in medicine, patients are surviving critical illnesses which in the past were
not survivable (Rattray & Hull, 2008). Along with this increasing survival rate, there is a high
likelihood that there will be increases in significant emotional and psychological problems
secondary to isolation, discomfort of tube insertions, sleep deprivation, physical confinement,
time-spacial disorientation, sensory overstimulation, depersonalization and loss of autonomy
(Davydow et al., 2009; Peris et al., 2011). In addition, with greater than 50% of the sample having
a preexisting psychiatric diagnosis as well as the potential for intra-intensive care unit psychiatric
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complications, the need is crucial for early recognition and intervention of psychiatric symptoms
among hospital ICU patient populations.
The second major finding of this study was the lack of correct medication reconciliation of
psychiatric medications. Although not statistically significant, a noteworthy amount of the sample
had the psychiatric medications abruptly stopped or held for a number of days. Findings revealed
that 8 out of 56 patients on antidepressant/mood stabilizers were restarted on their psychiatric
medications during their hospital stay, compared to those on antipsychotics (4 out of 16) or
anxiolytics (17 out of 33). Again while neither statistically significant nor generalizable, the
statistics in the sample indicated that 4 patients had abrupt interruptions in antipsychotic
medication prescriptions and 17 patients had abrupt interruptions in anxiolytic medication
prescriptions. While provider reasoning for stopping the medications were frequently not listed,
patients who have abrupt interruption in medications are subject to significant side effects or
withdrawal symptoms that may include nausea, vomiting, diarrhea, trouble sleeping, anxiety or
agitation which can compound the medical diagnoses and increase intra-intensive care unit
psychiatric complications.
The final major finding of this study was the high proportion (63%) of the sample with a
neurological admitting diagnosis. Even though the site of the study includes a comprehensive
stroke center accepting stroke patients from a wide geographical region, the high percentage
findings were not expected secondary to the ICU being a medical-surgical ICU. The neurological
diagnoses ranged from hemorrhagic or ischemic stroke to brain tumors and patients with
uncontrolled seizures. All of these neurological diagnoses place the study population at an
increased risk for psychiatric diagnosis, especially depression, anxiety or adjustment disorders.
For instance, Hacket and colleagues (2012) reported that approximately one-third of all patients
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who have experienced a stroke will suffer from post-stroke depression within the first year. In
addition, Arnold et al. (2009) found that almost half of all patients with brain tumors suffer from
depression. Abrupt interruptions of medication management can also have an effect on the central
nervous system. For example, the combination of the physiological stress response may result in
activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system.
Therefore, a sudden change in neurotransmitter functioning that is likely to result from
discontinuation of psychiatric medications could lead to significant physical and psychiatric
complications for patients. While the physiological stress from a stroke may not be mediated,
accurate medication reconciliation of psychiatric medications in ICU patients by providers can
potentially limit problems resulting from changes in the physiologic functioning of
neurotransmitters.
Overall the major findings of this DNP study were the increased rate of prior to admission
psychiatric diagnoses, the lack of appropriate medication reconciliation of psychiatric medications
and the abundance of neurological patients within the sample. These findings support the necessity
for: thorough assessments by healthcare providers to assure awareness of the patient psychiatric
diagnosis; focused education regarding psychiatric diagnoses emphasizing collaborative care, and
treatment emphasizing appropriate reconciliation of psychiatric medications for patients in ICU.
Limitations
A few limitations should be considered when interpreting the findings of this study. First,
there was a limitation in that the majority of the prior to admission psychiatric diagnoses found in
the medical records were patient reported versus physician reported. For instance, because the
majority of the psychiatric diagnoses were reported by the patients, the information was listed in
the past medical history section of the chart instead of the problem list which is provider designated
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with associated diagnostic codes.

Therefore, the reporting method led to difficulty when

identifying patients who meet the inclusion criteria; this limitation may have also contributed to
the finding related to increased rates of prior to admission psychiatric diagnoses in comparison to
national averages.
Secondly, the study data regarding medication reconciliation of psychiatric medications
may not show whether the complete process of medication reconciliation was completed.
Medication reconciliation requires the admitting nurse or provider to review the medication list
with the patient, family members or patient pharmacy to verify correct medications and dosages.
Because of EMR computer charting, it was not possible to explore whether the prior to admission
medications were actually reviewed with the patient on admission or simply carried over from a
prior visit. Nor could it be determined if medications were linked to a diagnostic code, thus
limiting the ability to see if, for example, an antipsychotic medication was being used as an adjunct
treatment for resistant depression or true psychotic symptoms.
Third, the increased rate of neurological admitting diagnoses (63%) may have influenced
the rates of prior to admission psychiatric diagnoses. Patients with stroke, brain tumors and
uncontrolled seizures have a high incidence of depression and anxiety (Hacket et al., 2012; Arnold
et al., 2009). However, this is consistent with the study setting of a comprehensive stroke center
and it contributes to the importance of addressing study implications.
Lastly, with the exploratory descriptive nature of these study the data is not generalizable
outside the current healthcare system. However, this study’s data has confirmed prior observations
and has value and utility in guiding changes in practices within the healthcare system to improve
patient outcomes.
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Implications for Future Doctoral Nursing Practice and Research
Psychiatric Diagnoses, Treatment Modalities and Patterns of Service Use
One recommendation regarding the prior to admission psychiatric diagnoses would be to
expand the study time period and sample size, to assure that the increased rate of prior to admission
psychiatric diagnoses is significant. If this is the case, the argument could be made to investigate
the study facility in comparison to other facilities within the system to determine if there are more
extensive trends between the admitting diagnosis and prior to admission psychiatric diagnosis.
Additionally, with an extended study time period and sample comparison of demographics, an
examination of treatment modalities and patterns of service use could be conducted between
patients who have a prior to admission psychiatric diagnosis and those who do not. This might
increase the chance of a more clear statistical comparison to determine if the prior to admission
psychiatric diagnosis makes a statistical difference in the rate of restraint use, psychiatric consults,
PRN medication use and length of stays.
A second recommendation regarding prior to admission psychiatric diagnosis, which
would help clarify diagnoses within the medical records, would be to implement collaborative care
within the healthcare system. The current care model within the study site deals with medical and
psychiatric illnesses separately. Psychiatric illnesses are handled and a psychiatric consult placed
only when the psychiatric illnesses supersedes the medical illness or becomes a major
complication. This is supported by the minimal use (less than 25.0%) of psychiatric consults
during the study period. Instituting the Collaborative Care Model developed by the American
Psychiatric Association (APA) and the Academy of Psychosomatic Medicine (APM) across the
healthcare system would operationalize psychiatric care from the primary care practice all the way
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up through inpatient hospital stays. This would improve access to evidence-based mental health
care across the entire healthcare system (APA, 2016).
Medication Reconciliation
The recommendation for evidence-based nursing practice surrounding medication
reconciliation would be to explore the current process. Currently, the study site’s institutional
policy is for the physician, physician’s assistant, nurse practitioner or registered nurse to make a
good faith effort to verify the patient’s home medications with the listing in the electronic medical
record from the patient, family members and/or significant others. However, problems may occur
if patients are unsure of their medication list or unable to communicate with providers. In addition,
the admitting provider may continue medications based on an expired list. Finally, not all of the
patient’s providers are linked through the same electronic medical record system. Further research
is required to address limitations and barriers to correct medication reconciliation along with
potential processes such as contacting patient pharmacies for current prescriptions or having the
reconciliation process completed by pharmacist.
Implications using DNP Essentials
In order to further examine the association of the demographic, clinical and treatment
characteristics of patients with both medical and psychiatric diagnosis admitted to an Intensive
Care Unit (ICU), a Doctoral Nursing Practice (DNP) graduate can be guided by principles evident
in the domains of several of the DNP Essentials. They include: Essential II, Organizational and
System Leadership for Quality Improvement; Essential III, Clinical Scholarship; Essential IV,
Information Systems/Technology; Essential VI, Interprofessional Collaboration; and Essential
VIII Advanced Nursing Practice (AACN, 2006).
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DNP graduates are also prepared to conceptualize new care delivery models which are
focused on the target population of patients in order to impact policies and procedures to meet the
overall health needs of this population (AACN, 2006). Examples include investigating barriers at
the system level that may need to be changed to help medical providers acknowledge psychiatric
diagnoses; in addition, elimination of barriers can facilitate correct medication reconciliation
among advanced practice registered nurses (APRNs), depending upon the practitioner’s specialty.
Specific scholarship efforts include additional retrospective chart reviews or a qualitative study to
investigate the providers’ and staffs’ opinions about psychiatric diagnoses to uncover undue biases.
DNP Essential III states that the DNP graduate is capable of using analytic methods to:
critically appraise existing literature; identify and compare variability between practice settings
and national benchmarks; and determine and implement the best evidence for practice (AACN,
2006). It is important to build on the findings of this study to identify other areas for additional
research as well as foster study by other DNP graduate who are prepared to appraise the literature
for connections. Most important, it is essential for all providers including DNP graduates to apply
this knowledge to solve the problems regarding patients with psychiatric conditions in general and
those admitted to the ICU. These efforts will enable the DNP graduate’s use of the combination
of essentials III and VI to lead the implementation of evidence-based, collaborative care.
The DNP graduate has advanced preparation in leading interprofessional collaboration and
overcoming hindrances to interprofessional practice; these skills can create highly fluid
collaborative teams (AACN, 2006). With foundational knowledge and evidence-based research,
the DNP graduate will be able to practice at the full scope of their APRN license and apply the
broad range of competencies of the DNP role, for the purpose of leading the development of
collaborative care models within the inpatient setting and between the inpatient and outpatient
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settings. They will also be prepared to develop implementation strategies to educate inpatient
providers in order to institute the collaborative care models.
Finally, within the context of APRN licensure, the DNP graduate will be able to apply
Essentials IV and VIII, to improve the overall medical reconciliation process, thus assuring that
patients’ medication regimens are continued rather than interrupted during inpatient treatment.
This too is an important area for additional research in order to better understand and eliminate the
barriers and limitations of medication reconciliation on a system level as well as assess the efficacy
of the current policies and procedures (AACN, 2006). Finally, DNP graduates will contribute to
optimal quality of care and patient safety through the implementation of new, evidence-based
interventions and development of policies and procedures to increase the accuracy of medication
reconciliations.

In addition, through the collaborative care model, the DNP can work to

incorporate the recommendations of Murphy et al. (2009) in working to have a pharmacist
complete the medication reconciliation or having staff contact the patient’s outside pharmacy in
order to obtain a current prescription list.
Conclusion
Approximately 20% of all adults in the United States will experience a mental illness
(APA, 2018). Furthermore, more than 40% of all individuals in the United States have a chronic
physical illness. Still others have a co-existing mental and physical health condition and these
patients tend to have even higher rates of chronic health conditions that are often secondary to the
side effects of psychotropic treatments, disparities in health care access and utilization of services
(CDC, 2012 & De Hert et al., 2011). There remains limited research concerning collaborative care
in the inpatient healthcare setting. However, the preliminary findings of this DNP project suggest
the need for more exploratory research that can guide practice and policies to enhance care for
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patients with psychiatric and medical comorbidities in the ICU setting. In conclusion, additional
research is needed to determine the needs of patients with co-existing conditions in acute care and
ICU settings as well as comparisons of a collaborative care model with those currently in place.
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Table 1. Measures
Variable name

Measures

Data Source

Level of measure

Statistical
analysis

Aim 1
Admission
Diagnosis

Neurologic

EMR

Nominal

Frequencies and
Percentages

EMR

Nominal

EMR

Nominal

Frequencies and
Percentages

Frequencies and
Percentages

Cardiac/Pulmonary
Other

Co-existing
Medical
Diagnosis

Neurologic

Frequencies and
Percentages

Cardiac/Pulmonary
Other

Psychiatric
diagnosis

Schizophrenia
Bipolar Disorder
Depression
Anxiety
PTSD
Intellectual Disability

Aim 2
Taking psych
meds prior to
admission

Yes or No

EMR

Nominal

Classification of
Psych med

Antipsychotic

EMR

Nominal

EMR

Nominal

Frequencies and
Percentages

Antidepressant/
Mood Stabilizer
Anxiolytic

Psych medication
reconciliation
status

(May not be mutually
exclusive)

Antipsychotics
- Continued in
less than 23 hours
from admission

Yes or No
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Frequencies and
Percentages

- Restarted
between 24 hours
and discharge

Yes or No

EMR

Nominal

Frequencies and
Percentages

- Restarted at
discharge only

Yes or No

EMR

Nominal

Yes or No

EMR

Nominal

Frequencies and
Percentages

- Restarted
between 24 hours
and discharge

Yes or No

EMR

Nominal

Frequencies and
Percentages

- Restarted at
discharge only

Yes or No

EMR

Nominal

- Continued in
less than 23 hours
from admission

Yes or No

EMR

Nominal

- Restarted
between 24 hours
and discharge

Yes or No

EMR

Nominal

Frequencies and
Percentages

Antidepressant/M
ood Stabilizer
- Continued in
less than 23 hours
from admission

Anxiolytic

Frequencies and
Percentages

Frequencies and
Percentages
Frequencies and
Percentages

Yes or No

EMR

Nominal

Frequencies and
Percentages

- ordered

Yes or No

EMR

Nominal

Chi-square

-Type (Medical or
Behavioral)

Yes or No

EMR

Nominal

Frequencies and
Percentages

- Sitter ordered

Yes or No

EMR

Nominal

Chi-square

PRN medication
given for anxiety
or agitation

Yes or No

EMR

Nominal

Chi-square

Yes or No

EMR

Nominal

Chi-square

- Restarted at
discharge only
Aim 3
Restraints

Psychiatric
Consult
- Ordered
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- hours from
admission to
ordered
- hours from order
placed to
completed
Length of Stay in
hospital
Length of Stay in
ICU

Disposition on
discharge

# of hours

EMR

Nominal

Frequencies and
Percentages

# of hours

EMR

Nominal

# of hours

EMR

Ratio

Mann-Whitney U
and interquartile
ranges

# of hours

EMR

Ratio

Mann-Whitney U
and interquartile
ranges

Home

EMR

Nominal

Frequencies and
Percentages

Frequencies and
Percentages

Rehab
Deceased

Demographics
Age

Age of participant in
years

EMR

Nominal

Mean with
standard deviation

Gender

Male, female

EMR

Nominal

Frequency

Race

White, Black,
Hispanic

EMR

Nominal

Frequency

Marital Status

Partnered, Nonpartnered

EMR

Nominal

Frequency

Table 2. Demographic characteristics of patients admitted to the ICU with a psychiatric diagnosis
(N=100)
Mean (SD) or n (%)
54.02 (15.01)

Age
Gender
Male
Female
Race/ethnicity
White
Black
Hispanic
Marital Status
Partnered
Non-partnered

40 (40%)
60 (60%)
90 (90%)
9 (9%)
1 (1%)
45 (45%)
55 (55%)
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Table 3. Clinical characteristics of patients admitted to the ICU with a psychiatric diagnosis
(N=100)
n (%)
Admission Diagnosis
Neurological
Cardiac/pulmonary
Other
Co-existing Medical Diagnosis a
Neurological
Cardiac/pulmonary
Other
Psychiatric Diagnosis a
Schizophrenia
Bipolar Disorder
Depression
Anxiety
PTSD
Intellectual Disability
Prescribed Psychiatric Medications Prior
to Admit
Yes
No

63 (63%)
15 (15%)
22 (22%)
53 (53%)
83 (83%)
83 (83%)
3 (3%)
9 (9%)
63 (63%)
75 (75%)
4 (4%)
3 (3%)

71 (71%)
29 (29%)

Types of Psychiatric Medicationsa (N=71)
Antipsychotic
Antidepressant/Mood Stabilizer
Anxiolytic
a

16 (16%)
56 (56%)
33 (33%)

patients may have more than one diagnosis, medication, etc.

Table 4. Medication Reconciliation of Prior to Admission Psychiatric Medications (N= 71)
Medication grouping

Antipsychotic
(N=16)
Yes
No
Antidepressant/
Mood Stabilizer
(N=56)
Yes
No

Medication restarted
within 23 hours
n (%)

Medication restarted
between 24 hours and
discharge
n (%)

Medication restarted
at discharge
n (%)

11 (68.8%)
5 (31.3%)

1 (20.0%)
4 (80.0%)

15 (93.8%)
1 (6.3%)

43 (76.8%)
13 (23.2%)

5 (38.5%)
8 (61.5%)

49 (87.5%)
7 (12.5%)
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Anxiolytic (N=33)
Yes
13 (39.4%)
No
20 (60.6%)
a
patients may be on more than one medication

3 (15.0%)
17 (85.0%)

24 (72.7%)
9 (27.3%)

Table 5. Treatment Modalities and Patterns of Service Use in Accordance with Prior to
Admission Psychiatric Medications.

Admission
Diagnosis
Neurological
Cardiac/pulmonary
Other
Co-existing Medical
Diagnosisa (% yes)
Neurological
Cardiac/pulmonary
Other
Restraint use (%)
Yes
No
PRN medication
used (%)
Yes
No
Psych consult
placed (%)
Yes
No
Disposition upon
discharge from
hospital
Home
Rehab
Hospice/Deceased
a

Antipsychotica
(N=16)

Antidepressant/Mooda
Stabilizer (N=56)

Anxiolytica
(N=33)

No prior
psych
medications
(N=29)

68.8%
18.8%
12.5%

71.4%
10.7%
17.9%

66.7%
9.1%
24.2%

48.3%
20.7%
31.0%

56.3%
75.0%
81.3%

55.4%
85.7%
83.9%

57.6%
87.9%
81.8%

41.4%
79.3%
82.8%

12.5%
87.5%

28.6%
71.4%

36.4%
63.6%

20.7%
79.3%

18.8%
81.3%

25.0%
75.0%

45.5%
54.5%

24.1%
75.9%

25.0%
75.0%

7.1%
92.9%

15.2%
84.8%

10.3%
89.7%

75.0%
25.0%
0.0%

64.3%
26.8%
8.9%

57.6%
30.3%
12.1%

82.8%
6.9%
10.3%

patients may be on more than one medication or co-existing medical diagnosis

(Significant comparisons in bold)
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Table 6. Length of Stay (hours) outcomes by Type of Prior to Admission Psychiatric
Medications
ICU LOS
Median (IQR)

p- value

Antipsychotica
(N=16)
Yes
39.0 (23.0-95.0)
No
45.0 (23.5-94.0)
Antidepressant/
Mood Stabilizera
(N=56)
46.5 (23.5-91.5)
Yes
42.0 (23.25-121.0)
No
Anxiolytica
(N=33)
Yes
45.0 (22.0-92.0)
No
44.0 (25.0-99.0)
No prior psych
medications
(N=29)
Yes
47.0 (22.5-168.0)
No
41.0 (23.0-90.0)
a
patients may be on more than one medication

Hospital LOS
Median (IQR)

p-value

0.768

90.0 (39.0-170.0)
62.0 (35.0-180.5)

0.566

0.892

59.0 (39.5-163.5)
75.0 (34.0-184.0)

0.624

0.895

90.0 (34.5-189.0)
62.0 (36.0-141.0)

0.545

0.250
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72.0 (35.0-203.0)
61.0 (35.0-170.0)

0.713

Appendix A: Data Collection Form
Comorbid Mental and Physical Health Conditions in an ICU setting
Nicole Ryan, RN, BSN, Primary Investigator
UK-IRB approved study 46928
1.
2.
3.
4.

Unique study number:
Age:
Gender:
Race:

5. Marital status:

___________
____
____ Male ____ Female ____ Other
_____ American Indian or Alaska Native
_____ Asian
_____ Black or African American
_____ Hispanic or Latino
_____ Native Hawaiian or Other Pacific Islander
_____ Other
_____ White or Caucasian
_____ Divorced
_____ Legally Separated
_____ Married
_____ Other
_____ Significant Other
_____ Single
_____ Unknown
_____ Widowed

6. Admission Diagnosis:

_____ Neuro
_____ Respiratory
_____ Cardiovascular
_____ Gastrointestinal
_____ Genitourinary
_____ Endocrine
_____ Malignancy
_____ Infectious Disease
_____ Musculoskeletal
_____ EENT
_____ Integumentary
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7. Other Medical Diagnosis:

_____ Neuro
_____ Respiratory
_____ Cardiovascular
_____ Gastrointestinal
_____ Genitourinary
_____ Endocrine
_____ Malignancy
_____ Infectious Disease
_____ Musculoskeletal
_____ EENT
_____ Integumentary

8. Psychiatric Diagnosis:

_____ Schizophrenia
_____ Bipolar Disorder
_____ Depression
_____ Anxiety
_____ PTSD
_____ Intellectual Disability

9. Psychiatric Medication Prior to Admission: _____ Yes
_____ No
____ Antipsychotic

10. Type of Psychiatric Medication:

_____ Antidepressant
_____ Mood Stabilizer
_____ Stimulant
_____ Anxiolytic
11. Psychiatric Medication Continued in less than 23 hours:
_____ Yes _____ No
Which ones? __________________________
12. Psychiatric Medication Restarted between 24 hours and discharge: ____ Yes ____ No
Which ones? __________________________
13. Psychiatric Medication Restarted at Discharge:
_____ Yes _____ No
14. Restraints Ordered:
_____ Yes _____ No
15. Type of restraints:
_____ Medical _____ Behavioral
16. Sitter ordered:
_____ Yes _____ No
17. PRN medication for anxiety or agitation:
_____ Yes _____ No
Which ones? ___________________________
18. Psychiatry consult ordered:
_____ Yes _____ No
19. Hours from admission to psychiatric consult placed: _____ hours
20. Hours between psychiatric consult order placed to completed: _____ hours
21. ICU length of stay:
_____ days _____ hours
40

22. Hospital length of stay:
23. Disposition on discharge:

_____ days _____ hours
_____ Home
_____ Acute rehab
_____ Subacute rehab
_____ Inpatient psych
_____ Nursing home
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Appendix B: Data Coding Form
Chart Audit Data Coding Form
Patient Identification Code

Numeric

Age

Numeric

Gender

Male-0, Female-1

Race

See Key

Marital Status

See Key

Admission Diagnosis

See Key

Co-existing Diagnosis

See Key

Psychiatric Diagnosis

See Key

Psychiatric medication prior to admission

Yes- 0, No- 1

Type of psychiatric medication

See Key

Psychiatric medication continued less than
23 hours

Numeric

Psychiatric medication restarted between
24 hours and discharge

Numeric

Psychiatric medication restarted at
discharge

Numeric

Restraints ordered

Yes- 0, No- 1

Type of restraints

Medical- 0, Behavioral- 1

Sitter

Yes- 0, No- 1

PRN medication for anxiety or agitation

Yes- 0, No- 1

Psychiatric Consult ordered

Yes-0, No-1

Hours between admission and psychiatric
consult place

Numeric

Hours between psychiatric consult ordered
and completed

Numeric

ICU Length of stay in hours

Numeric

Hospital Length of stay in hours

Numeric
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Disposition on Discharge

See key

Key:
Ethnicity

Psychiatric Medication

Black or African American: 1

Antipsychotic: 1

Hispanic or Latino: 2

Antidepressant/Mood Stabilizer: 2

White or Caucasian: 3

Anxiolytic: 3

Marital Status

Disposition on Discharge

Partnered: 1

Home: 1

Non-partnered: 2

Rehab: 2

Admission Diagnosis

Hospice/deceased: 3

Neurological: 1
Cardiac/pulmonary: 2
Other: 3
Co-existing Diagnosis
Neurological: 1
Cardiac/pulmonary: 2
Other: 3
Psychiatric Diagnosis
Schizophrenia: 1
Bipolar: 2
Depression: 3
Anxiety: 4
PTSD: 5
Intellectual Disability: 6
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